STAT6 and neoplasm: One of the most prominent signaling pathways responsible to skew immune cells towards a presumably tumor promoting type 2 profile comprises IL-4 receptor engagement and subsequent activation of signal transducer and activator of transcription 6 (STAT6) [4].